Known targets — ChEMBL curated mechanism
GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQ
The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.55 |
| ▸ | APOBEC3A | P31941 | 2/20 | 0.55 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.42 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.42 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.42 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.37 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL14861565 | 1.00 | LMNA (0.55) | LMNAAPOBEC3AAPOBEC3GKMT2ABBOX1 | |
| Water SCHEMBL23525630 | 1.00 | LMNA (0.55) | LMNAAPOBEC3AAPOBEC3GKMT2ABBOX1 | |
| Water SCHEMBL14914159 | 0.97 | BBOX1 (0.54) | LMNAAPOBEC3AAPOBEC3GKMT2ABBOX1 | |
| SCHEMBL3043744 | 0.97 | LMNA (0.57) | LMNAAPOBEC3AAPOBEC3GKMT2ABBOX1 | |
| SCHEMBL417495 | 0.97 | LMNA (0.57) | LMNAAPOBEC3AAPOBEC3GKMT2ABBOX1 | |
| SCHEMBL12638422 | 0.97 | LMNA (0.57) | LMNAAPOBEC3AAPOBEC3GKMT2ABBOX1 | |
| SCHEMBL3037609 | 0.97 | LMNA (0.57) | LMNAAPOBEC3AAPOBEC3GKMT2ABBOX1 | |
| SCHEMBL923466 | 0.97 | LMNA (0.57) | LMNAAPOBEC3AAPOBEC3GKMT2ABBOX1 | |
| SCHEMBL3040478 | 0.97 | LMNA (0.57) | LMNAAPOBEC3AAPOBEC3GKMT2ABBOX1 | |
| Hydrochloric Acid SCHEMBL29716086 | 0.94 | BBOX1 (0.56) | LMNAAPOBEC3AAPOBEC3GKMT2ABBOX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3801895-B1 | METHOD FOR SYNTHESIZING A COMPOSITE MATERIAL CONSISTING OF A MIXTURE OF AFX- AND BEA-STRUCTURE ZEOLITES IN THE PRESENCE OF AN ORGANIC NITROGEN-CONTAINING STRUCTURING AGENT | IFP ENERGIES NOW (FR) | 2023-05-03 | — | — | EP | claimed |
| EP-3801894-B1 | CATALYST COMPRISING A MIXTURE OF AN AFX-STRUCTURE ZEOLITE AND A BEA-STRUCTURE ZEOLITE AND AT LEAST ONE TRANSITION METAL FOR SELECTIVE REDUCTION OF NOX | IFP ENERGIES NOW (FR) | 2023-08-09 | — | — | EP | disclosed |
| EP-3801895-B1 | METHOD FOR SYNTHESIZING A COMPOSITE MATERIAL CONSISTING OF A MIXTURE OF AFX- AND BEA-STRUCTURE ZEOLITES IN THE PRESENCE OF AN ORGANIC NITROGEN-CONTAINING STRUCTURING AGENT | IFP ENERGIES NOW (FR) | 2023-05-03 | — | — | EP | disclosed |
| EP-2766303-B1 | SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES | EXXONMOBIL RES & ENG CO (US) | 2017-11-22 | — | — | EP | disclosed |
| US-9035058-B2 | Synthesis of MSE-framework type molecular sieves | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2015-05-19 | — | — | US | disclosed |
| US-20150087841-A1 | SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2015-03-26 | — | — | US | disclosed |
| US-8916130-B2 | Synthesis of MSE-framework type molecular sieves | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2014-12-23 | — | — | US | disclosed |
| US-20130115163-A1 | SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2013-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150087841-A1 | SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES | MRPS2, B2M, UFM1 | LMNA 3785/4885APOBEC3A 4518/4885APOBEC3G 4254/4885 |
| US-20130115163-A1 | SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES | MRPS2, UFM1, B2M | LMNA 3760/4885APOBEC3A 4483/4885APOBEC3G 4175/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.